GBIC Completes Acquisition of Six Oil Wells and Retains Triton American Energy to Manage Field Operations.

Shareholders to Receive Earnings from Herbal and Energy Operations

HOUSTON -- Gulf Biomedical Corporation (PINKSHEETS: GBIC) is pleased to announce they have completed the acquisition of six oil wells of which four are in the Southern Pacific Company Lease and two are in the Sadie Epstein Lease. All wells are located in the Luling, Caldwell County, Texas area and are anticipated to generate long-term residual revenue. Income from well operations will directly flow into Gulf Biomedicals earnings. Gulf Biomedical retains fifty percent working interest in the six wells. The Company also receives revenue from residual gas sales.

Under the terms of agreement, Gulf Biomedical will utilize Triton American Energy (PINKSHEETS: TRAE) to manage all field operations. Triton American Energy has a strong history of managing well operations within Texas.

Don West, President of Gulf Biomedical stated "This is an exciting time for our company. We are fully diversified in two high growth industries which generate residual revenue. Our latest acquisition of six oil wells is anticipated to accelerate earnings and corporate expansion." Mr. West continued to state "Our well acquisitions will in no way affect our growing order demand of herbal products. We will continue to build out our product lines, pursue infomercials and increase our dedicated customer base."

About Gulf Biomedical:

Gulf Biomedical (PINKSHEETS: GBIC) is a diversified company focused on generating residual revenue in high growth industries such as herbal products and oil and gas production. The Company herbal division targets four high revenue generating segments, Erectile Dysfunction, Hair Restoration, Anti-Depression and Weight Loss. All products are created to be safe, reliable and backed by quality customer service. Over 91 million people within the United States take herbal supplements to improve their health. Gulf Biomedical oil and gas division is structured to take advantage of today's rising energy cost, while reducing as much financial risk as possible. This division targets the small to moderate operations (usually 1-50 well projects). These wells can be worth hundreds of millions of dollars in revenue but require more hands-on attention then major producers are willing to give.

For more information on Gulf Biomedical or becoming an herbal distributor, please contact Investor Relations at [phone] or Customer Service at 973-375-5002.

To subscribe to receive updates on Gulf Biomedicals latest product developments or stock updates please visit the website at http://www.gulfbiomedicalgroup.com or www.Herbalstore.us.

Disclaimer: This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.